At Estel, we just don't sell. We care.

Shop

RIVATAS (RIVAROXABAN) TAB 15MG

16.25

Add to wishlist Add to compareAsk about product
SKU: A-374 Category:

Description

RIVATAS (Rivaroxaban) 15 mg tablets contain rivaroxaban as the active ingredient.

Primary Medical Uses:
– Used to prevent and treat blood clots.
– Indicated for treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
– Used after initial treatment phase to reduce the risk of recurrence of DVT and PE.
– May be used for prevention of stroke in patients with non-valvular atrial fibrillation, typically in different dosing regimens.

Drug Class or Type:
– Oral anticoagulant, a direct factor Xa inhibitor.

General Mechanism of Action:
– Rivaroxaban works by selectively inhibiting factor Xa, an enzyme essential for blood clot formation, thereby preventing the development of harmful clots.

Common Forms:
– Oral tablets available in various strengths, including 15 mg.

Dosage Instructions:
– The 15 mg dose is often used as part of an initial treatment regimen, commonly taken twice daily for a specified duration before switching to a maintenance dose.
– Tablets should be taken with food to enhance absorption.
– Dosage and duration depend on the specific condition and patient response.
– Follow healthcare provider instructions carefully.

Side Effects, Contraindications, or Interactions:
– Common side effects include bleeding, bruising, and gastrointestinal upset.
– Contraindicated in patients with active bleeding or severe hypersensitivity to rivaroxaban.
– Use caution in patients with impaired kidney or liver function.
– Increased bleeding risk when combined with other anticoagulants, antiplatelet drugs, or NSAIDs.
– Inform healthcare providers about all medications taken to avoid interactions.

RIVATAS 15 mg is part of anticoagulant therapy aimed at managing and preventing blood clots and should be used under medical supervision.

Reviews

There are no reviews yet.

Be the first to review “RIVATAS (RIVAROXABAN) TAB 15MG”

Your email address will not be published. Required fields are marked *